Repurposing efavirenz, the HIV antiretroviral drug for Chikungunya virus infection.
Sanketkumar Nehul, Ruchi Rani, Priyanshu Walia…·Shailly Tomar
This study identifies efavirenz's anti-CHIKV activity and shows it inhibits viral replication by targeting minus-sense RNA synthesis, suggesting its repurposing for antiviral therapy.